Last Updated:
Name Designation Appointment Date Status
Kishorkumar Jagdishchandra Arya

Appointed as Director since March 1997

Director 17-Mar-1997 Current
Name Designation Appointment Date Status
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Inderjeet Jagdishchandra Arya

Appointed as Director since March 1997

Director 17-Mar-1997 Current

People Timeline

Explore the timeline of key personnel in Rajat Pharmaceuticals Private Limited's leadership journey.

Loading...
Contact Details
  • Address Rajat Enclave, 102-103,A,Winggayatri Darshan Thakur Complex Kandivli, Mumbai 400 101 Maharashtra, India
  • Telephone Upgrade
  • Email Upgrade
  • Pin Code
  • Country India
  • Website -
Frequently Asked Questions
How can I contact Rajat Pharmaceuticals Private Limited?
You can contact Rajat Pharmaceuticals Private Limited through their registered address at Rajat Enclave, 102-103,A,Winggayatri Darshan Thakur Complex Kandivli, Mumbai 400 101 Maharashtra, India, or via their website if available. Social media links are also provided where applicable.
Who are the current directors of Rajat Pharmaceuticals Private Limited?
The current directors of Rajat Pharmaceuticals Private Limited are listed above in the "Current Directors & Signatories" section. You can view their names, designations, and appointment dates.
  • KISHORKUMAR JAGDISHCHANDRA ARYA
  • INDERJEET JAGDISHCHANDRA ARYA
How can I access past director details?
Past director details are available under the "Past Directors & Signatories" tab. You may need to upgrade your subscription to view detailed information.
Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available